Halozyme Therapeutics Inc (NASDAQ:HALO)

57.72
BATS BZX Real-Time Price
As of Dec 07
 0.00 / 0.00%
Today’s Change
31.36
Today|||52-Week Range
59.46
+43.55%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 55.00, with a high estimate of 65.00 and a low estimate of 23.00. The median estimate represents a -4.71% decrease from the last price of 57.72.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.27
Sales
$191.3M
Reporting Date
Feb 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -37.66%
 
 
 
 
 
 
Growthannually -50.57%
 
 
 
 
 
 

Sales

Growthquarterly -8.44%
 
 
 
 
 
 
Growthannually 52.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.